Ambulatory insulin infusion administration set/reservoir kit
Australia TGA ARTG Registered Device · Roche Diabetes Care Australia Pty Ltd · Roche Diabetes Care GmbH · Class IIb · Started November 12, 2018
Good Name: Roche Diabetes Care Australia Pty Ltd - Ambulatory insulin infusion administration set/reservoir kit
- Risk Class
- Class IIb
- Product Type
- Procedure Pack
- ARTG Category
- General
- Start Date
- November 12, 2018
- Effective Date
- November 12, 2018
- Country
- Germany
- Address
- Sandhofer strasse 116, Mannheim, 68305
The supply kit is intended to conveniently provide some of the components necessary for the ambulatory administration of insulin to a patient with diabetes mellitus.
Access comprehensive regulatory information for Ambulatory insulin infusion administration set/reservoir kit in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Roche Diabetes Care Australia Pty Ltd, manufactured by Roche Diabetes Care GmbH in Germany. The device registration started on November 12, 2018.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.